文献速递围术期管理与 ERAS胃肠外科急腹症与外科感染

儿童非急诊手术术后抗菌预防与手术部位感染无医院水平相关性

Correlation Between Postoperative Antimicrobial Prophylaxis Use and Surgical Site Infection in Children Undergoing Nonemergent Surgery.
PubMed 文献 · JAMA Surg · 2022-01-01

调整术式组合与患者特征后,术后预防使用与SSI率总体无相关性(r=0.13;P=.20),按SSI类型和外科专科分层亦无相关性。

要点

  • 术后抗菌预防使用率在医院间差异极大,但未发现与SSI率相关。
  • 调整术式组合和患者特征后,医院水平术后预防与SSI无相关性。
  • 结果不支持常规术后继续抗菌预防以降低儿童SSI。

核心结论

  • 调整术式组合和患者特征后,医院水平术后抗菌预防使用与SSI率无相关性。

研究设计与样本

  • 多中心队列研究,使用ACS NSQIP-Pediatric 2019年6月至2021年6月30天术后SSI数据,补充病历审查获取抗生素使用数据。
  • 纳入93家参与ACS NSQIP-Pediatric Surgical Antibiotic Prophylaxis Stewardship Collaborative医院的小于18岁非急诊手术患儿。
  • 排除抗生素过敏、免疫功能障碍及手术时需静脉抗生素的既有感染患者。

主要发现

  • 41.6%接受术后预防,医院范围0%-71.2%。
  • 术后预防使用OR在医院间跨度190倍(OR 0.10-19.30),SSI率OR跨度4倍(OR 0.55-1.90)。
  • 总体术后预防使用与SSI率无相关性(r=0.13;P=.20)。
  • 切口SSI(r=0.08;P=.43)和器官腔隙SSI(r=0.13;P=.23)分层均无相关性。
  • 普通外科(r=0.02;P=.83)、泌尿外科(r=0.05;P=.64)、整形外科(r=0.11;P=.35)、耳鼻喉科(r=-0.13;P=.25)、骨科(r=0.05;P=.61)、神经外科(r=0.02;P=.85)均无相关性。

临床怎么用

  • 儿童非急诊手术中,术后继续抗菌预防不应视为降低SSI的常规策略。
  • 医院应关注术式组合和患者特征差异,而非以术后预防使用率作为质量指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Use of postoperative antimicrobial prophylaxis is common in pediatric surgery despite consensus guidelines recommending discontinuation following incision closure. The association between postoperative prophylaxis use and surgical site infection (SSI) in children undergoing surgical procedures remains poorly characterized. OBJECTIVE: To evaluate whether use of postoperative surgical prophylaxis is correlated with SSI rates in children undergoing nonemergent surgery. DESIGN, SETTING, AND PARTICIPANTS: This is a multicenter cohort study using 30-day postoperative SSI data from the American College of Surgeons' Pediatric National Surgical Quality Improvement Program (ACS NSQIP-Pediatric) augmented with antibiotic-use data obtained through supplemental medical record review from June 2019 to June 2021. This study took place at 93 hospitals participating in the ACS NSQIP-Pediatric Surgical Antibiotic Prophylaxis Stewardship Collaborative. Participants were children (<18 years of age) undergoing nonemergent surgical procedures. Exclusion criteria included antibiotic allergies, conditions associated with impaired immune function, and preexisting infections requiring intravenous antibiotics at time of surgery. EXPOSURES: Continuation of antimicrobial prophylaxis beyond time of incision closure. MAIN OUTCOMES AND MEASURES: Thirty-day postoperative rate of incisional or organ space SSI. Hierarchical regression was used to estimate hospital-level odds ratios (ORs) for SSI rates and postoperative prophylaxis use. SSI measures were adjusted for differences in procedure mix, patient characteristics, and comorbidity profiles, while use measures were adjusted for clinically related procedure groups. Pearson correlations were used to examine the associations between hospital-level postoperative prophylaxis use and SSI measures. RESULTS: Forty thousand six hundred eleven patients (47.3% female; median age, 7 years) were included, of which 41.6% received postoperative prophylaxis (hospital range, 0%-71.2%). Odds ratios (ORs) for postoperative prophylaxis use ranged 190-fold across hospitals (OR, 0.10-19.30) and ORs for SSI rates ranged 4-fold (OR, 0.55-1.90). No correlation was found between use of postoperative prophylaxis and SSI rates overall (r = 0.13; P = .20), and when stratified by SSI type (incisional SSI, r = 0.08; P = .43 and organ space SSI, r = 0.13; P = .23), and surgical specialty (general surgery, r = 0.02; P = .83; urology, r = 0.05; P = .64; plastic surgery, r = 0.11; P = .35; otolaryngology, r = -0.13; P = .25; orthopedic surgery, r = 0.05; P = .61; and neurosurgery, r = 0.02; P = .85). CONCLUSIONS AND RELEVANCE: Use of postoperative surgical antimicrobial prophylaxis was not correlated with SSI rates at the hospital level after adjusting for differences in procedure mix and patient characteristics.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. He K, Nayak RB, Allori AC, et al. Correlation Between Postoperative Antimicrobial Prophylaxis Use and Surgical Site Infection in Children Undergoing Nonemergent Surgery. JAMA Surg. 2022. PMID: 36260310. doi:10.1001/jamasurg.2022.4729

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。